Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The growth hormone–releasing hormone receptor (GHRHR) is a G protein-coupled receptor (GPCR) that specifically binds growth hormone-releasing hormone (GHRH). Upon binding its ligand, GHRH, the receptor activates a stimulatory Gs protein, which in turn triggers the production of cyclic AMP (cAMP) via adenylate cyclase. Binding of GHRH to its receptor stimulates both synthesis and secretion of growth hormone (GH). Mutations in the GHRHR gene can cause isolated growth-hormone deficiency (IGHD), leading to short stature or Dwarfism of Sindh syndrome. Dysregulation or abnormal expression has been implicated in disorders involving GH excess or deficiency as well as some cancers due to aberrant signaling by certain splice variants.
Activates adenylyl cyclase → ↑cAMP → PKA activation
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Growth Hormone–Releasing Hormone Receptor (GHRHR).